A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2004
12/16/2004	WO2004109290A2 Methods for identifying modulators of kinesin activity
12/16/2004	WO2004109288A1 Method for diagnosing inflammatory bowel disease
12/16/2004	WO2004108961A1 Therapeutic and diagnostic means for papillomas and other diseases involving ped/pea-15
12/16/2004	WO2004108948A2 Systems, methods and kits for characterizing phosphoproteomes
12/16/2004	WO2004108928A1 Cholesterol biosynthesis pathway modulators and uses thereof
12/16/2004	WO2004108927A1 Laminin 5b
12/16/2004	WO2004108923A1 Cd47 partal peptdie and anti-shps-1 monoclonal antibody
12/16/2004	WO2004108920A1 Method of screening anti-obestic medicine, and obesity model animal
12/16/2004	WO2004108885A2 Fc chimeric proteins with anti-hiv drugs
12/16/2004	WO2004108883A2 Transducible dna-binding proteins
12/16/2004	WO2004108765A2 Extracellular aspergillus polypeptides
12/16/2004	WO2004108763A2 Mutants of the factor vii epidermal growth factor domain
12/16/2004	WO2004108761A2 Canine ghrh gene, polypeptides and methods of use
12/16/2004	WO2004108757A2 Antimicrobial polypeptides
12/16/2004	WO2004108752A1 Antimicrobial polypeptides
12/16/2004	WO2004108687A2 Nitrogen-containing heteroaryl derivatives for the treatment of hcv-infection
12/16/2004	WO2004108667A2 Formation of novel erythropoietin conjugates using transglutaminase
12/16/2004	WO2004108167A1 Plasmid encoding fibroblast growth factor for the treatment of hypercholesterolemia or diabetes associated angiogenic defects
12/16/2004	WO2004108166A1 Epas1 gene transfer to improve cell therapy
12/16/2004	WO2004108160A1 Osteogenesis-promotion enhancer and method of screening the same
12/16/2004	WO2004108154A1 Prevention of pulmonary immunopathology using mutant bacterial toxins
12/16/2004	WO2004108153A1 Combined pharmaceutical preparations for the treatment of cancer, containing glutaminase and antineoplastic anthracyclines or platinum compounds
12/16/2004	WO2004108152A1 Stable, aqueous solution of human erythropoietin, not containing serum albumin
12/16/2004	WO2004108151A1 Inhibition of sars coronavirus infection with clinically approved antiviral drugs
12/16/2004	WO2004108144A1 Cell-containing preparations
12/16/2004	WO2004108091A2 Antimicrobial flush solutions
12/16/2004	WO2004108088A2 Methods and compositions for interferon therapy
12/16/2004	WO2004108077A2 Method of mitigating the adverse effects of il-2
12/16/2004	WO2004108074A2 Vascular endothelial growth factor fusion constructs and uses thereof
12/16/2004	WO2004108071A2 Targeting polypeptides to the central nervous system
12/16/2004	WO2004108070A2 Releasable polymeric conjugates based on aliphatic biodegradable linkers
12/16/2004	WO2004108069A2 Compositions and methods for promoting neuronal outgrowth
12/16/2004	WO2004108066A2 Neuronal regeneration and compound administration methods
12/16/2004	WO2004107881A1 Nutritional compositions and use thereof
12/16/2004	WO2004097034A3 Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 4 (tmprss4)
12/16/2004	WO2004096844A3 Group 1 mite polypeptide variants
12/16/2004	WO2004094991A3 Treatment or prevention of respiratory viral infections with alpha thymosin peptides
12/16/2004	WO2004091646A3 Use of slurp-1 for treating diseases related to acetylcholine receptors dysfunction
12/16/2004	WO2004087211A3 Inhibitors of phosphodiesterases in infertility
12/16/2004	WO2004087206A3 Methods of treating diabetes by blocking vegf-mediated activity
12/16/2004	WO2004081198A3 Methods for modulating angiogenesis with apelin compositions
12/16/2004	WO2004075901A3 Compositon for increasing levels of hormones and a method for preparation of said composition
12/16/2004	WO2004065410A3 Mntf peptides and compositions and methods of use
12/16/2004	WO2004062602A3 Compositions and methods for targeted biological delivery of molecular carriers
12/16/2004	WO2004061423A3 Compositions and methods for diagnosing and treating colon cancers
12/16/2004	WO2004058287A3 Methods of treating neurological conditions with hematopoeitic growth factors
12/16/2004	WO2004050685A3 Antifungal therapeutic agents
12/16/2004	WO2004033481A3 Igf-binding protein-derived peptide or small molecule
12/16/2004	WO2004029253A3 Nucleic acid sequences coding for proteolytic enzymes in the form of specific proteases, corresponding polypeptides and use of the same
12/16/2004	WO2004029218A3 Receptors and membrane-associated proteins
12/16/2004	WO2004022697A3 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof
12/16/2004	WO2004016646A3 Peptide modulators of tumour specific pyruvate kinase subtype m2 (m2-pk)
12/16/2004	WO2004014940A3 PEPTIDES AS SOLUBILIZING EXCIPIENTS FOR TRANSFORMING GROWTH FACTOR ß PROTEINS
12/16/2004	WO2004011487A8 Fluoro-alkyl-cyclopeptide derivatives having anti-integrin activity
12/16/2004	WO2004010951A3 Method of treating tumors
12/16/2004	WO2004006848A3 Combination therapies with ftc for the treatment of hepatitis b virus infection
12/16/2004	WO2003105908B1 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
12/16/2004	WO2003090514A8 Adipocyte complement related protein zacrp14
12/16/2004	WO2003087115B1 Oligomeric compounds having modified phosphate groups
12/16/2004	WO2003066666A3 Compositions and methods for treatment of vitamin d deficiency
12/16/2004	WO2003059268A3 A novel germ cell-specific contraceptive target
12/16/2004	WO2003054152A3 Novel nucleic acids and polypeptides
12/16/2004	WO2003050245A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/16/2004	WO2003027254A3 15625 receptor, a novel g-protein coupled receptor
12/16/2004	WO2003013425A9 In vitro assays for inhibitors of hiv capsid conformational changes and for hiv capsid formation
12/16/2004	WO2003005953A3 Viral proteins capable of binding lar
12/16/2004	WO2002070665A8 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
12/16/2004	US20040255343 Caspase-9 deficient animals and the use thereof
12/16/2004	US20040254362 Nucleotide sequences coding polypeptide associate with fatty acid metabolism for use in diagnosis, prevention and treatment of obesity, diabetes and heart disease
12/16/2004	US20040254359 Antisense modulation of stearoyl-coa desaturase expression
12/16/2004	US20040254354 Extracellular matrix-binding proteins from Staphylococcus aureus
12/16/2004	US20040254351 Hyperglycosylated polypeptides
12/16/2004	US20040254350 Immunomodulatory protein for use in diagnosis, treatment, and prevention of immune system, neurological, developmental, muscle and cell proliferative disorders
12/16/2004	US20040254349 Mycobacterial antigens expressed under low oxygen tension
12/16/2004	US20040254348 Opiate receptor therapeutic protein/peptides for use in pain relief and management
12/16/2004	US20040254345 for increasing gastric motility
12/16/2004	US20040254344 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
12/16/2004	US20040254343 Crystals of N2-(N,N-dimethyl-L-valyl)-N-[(1S,2R)-2-methoxy-4-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[(2-phenylethyl)amino]propyl]-1-pyrrolidinyl]-1-[(S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamide with potent antitumor activity
12/16/2004	US20040254340 Expression vetor comprising cell surface glycoprotein for use in prevention and treatment of neurodegenerative disorders; memory enhancement and learning
12/16/2004	US20040254339 Preparation and use of cyclic and branched peptides and their labelled derivatives as therapeutic agents, cholecystokinin agonists or antagonists, and diagnostic agents to identify and locate tumours
12/16/2004	US20040254338 Melanin-concentrating hormone antagonists
12/16/2004	US20040254153 Potentiation adenosine 3',5'-cyclic monophosphate in urogenital system of female
12/16/2004	US20040254144 Use of inhibitors of heparin-binding epidermal growth factor or inhibitors of its receptors for the preparation of drugs useful for treating myeloma
12/16/2004	US20040254139 Dna sequences, Rna sequences; binding to tumor necrosis factor
12/16/2004	US20040254138 Vectors containing genomic Dna, Rna encoding replacement gene; bone disordwers; vision defects; antidepressants; anticancer agents
12/16/2004	US20040254137 Nucleotide sequences; for therapy of bone disorders, chondrondysplasis; biodrug; activation caspase signaling cascade
12/16/2004	US20040254136 Antisense oligonucleotides and related methods for regulating cell death
12/16/2004	US20040254135 Administering enzyme inhibitor; moderate metabolism
12/16/2004	US20040254134 Modulating heart cells; administering polynucleotide; adjust contraction
12/16/2004	US20040254133 Autoimmune disease; antidiabetic agents; multiple sclerosis; antiarthritic agents; Crohn's disease
12/16/2004	US20040254132 Ovary-specific genes and proteins
12/16/2004	US20040254129 In aqueous solution;prevent cell damage; mixture with drug or nitritional supplment
12/16/2004	US20040254122 increasing the tryptophan:large neutral amino acids ratio in blood by orally administering a rapidly digestible blend of no more than 40 g carbohydrate and a high tryptophan containing protein
12/16/2004	US20040254120 Stimulating high density lipoproteins; osteoporosis; detoxification
12/16/2004	US20040254119 Polypeptide conjugates with extended circulating half-lives
12/16/2004	US20040254118 Reducing axon degeneration with proteasome inhibitors
12/16/2004	US20040254117 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
12/16/2004	US20040254116 Contactor tissue with transforming growth factor kinase receptors; modulate cell proliferation
12/16/2004	US20040254115 Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator
12/16/2004	US20040254114 Genetic engineering

1 ... 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 ... 3163